Immune Effector Cell-Associated HLH-Like Syndrome (IEC-HS) in CAR-T and TCE-Treated Myeloma and B-Cell Malignancies: Insights from a Pharmacovigilance Study.
- DOI
- 10.1016/j.jtct.2025.12.947
- Published
- 2026 Mar
- Container
- Transplantation and cellular therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtct.2025.12.947,
title = {Immune Effector Cell-Associated HLH-Like Syndrome (IEC-HS) in CAR-T and TCE-Treated Myeloma and B-Cell Malignancies: Insights from a Pharmacovigilance Study.},
author = {Irfan S and Ayoobkhan FS and Vojjala N and Qureshi R and Rahman R and Kamboj I and Abdallah AO and McGuirk J and Mahmoudjafari Z and Lutfi F and Ahmed N},
year = {2026},
journal = {Transplantation and cellular therapy},
doi = {10.1016/j.jtct.2025.12.947},
url = {https://doi.org/10.1016/j.jtct.2025.12.947}
}RIS
TY - JOUR TI - Immune Effector Cell-Associated HLH-Like Syndrome (IEC-HS) in CAR-T and TCE-Treated Myeloma and B-Cell Malignancies: Insights from a Pharmacovigilance Study. AU - Irfan S AU - Ayoobkhan FS AU - Vojjala N AU - Qureshi R AU - Rahman R AU - Kamboj I AU - Abdallah AO AU - McGuirk J AU - Mahmoudjafari Z AU - Lutfi F AU - Ahmed N PY - 2026 JO - Transplantation and cellular therapy DO - 10.1016/j.jtct.2025.12.947 UR - https://doi.org/10.1016/j.jtct.2025.12.947 ER -
APA
S, I., FS, A., N, V., R, Q., R, R., I, K., AO, A., J, M., Z, M., F, L., & N, A. (2026). Immune Effector Cell-Associated HLH-Like Syndrome (IEC-HS) in CAR-T and TCE-Treated Myeloma and B-Cell Malignancies: Insights from a Pharmacovigilance Study.. Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2025.12.947
Source records
- pubmed · retrieved 2026-09-26T03:28:15.397Z